Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Maceron Sep 03, 2019 6:07pm
114 Views
Post# 30092201

RE:RE:RE:RE:Fast Track Status

RE:RE:RE:RE:Fast Track Status
Hempdoc wrote:
Quattro74 wrote:
Maybe they left it up to the patient? Here is your choice sir/maam, we strap you in, put you out and use this older solidstate tech over half a day. Or you wait a few weeks for reb approval and we can use this new, comfortable, flexible tech with a local anesthetic, and you're out in two hours???

Macer wrote:
Eoganacht wrote: In the June 27 NR Shawn Shirazi wrote: 

"We can now proceed with completing and filing an IND application with request for fast track designation, which pending approval, would allow the Company to expeditiously and effectively extend our clinical study into the US, to qualify and onboard clinical sites."

If we receive fast track status, accelerated approval becomes possible once we have demonstrated the achievement of an intermediate clinical endpoint, such as complete response in a specified number of patients after a specified period of time after the initial treatment.


This ia very feasible in my opinion.
As for the laser, don’t get me wrong. I am all for optimization. The company said for itself that they did not need to delay treatment in the study to wait for the REB approval.
Macer

 


I don’t think they would enroll a patient to give that patient a choice to wait an undetermined amount of time IMO...too much risk to the patient & such a wait has the real potential to negatively impact the data.



Shawn mentioned at the AGM that there a 6 week period between TURBT procedure and TLD 1433 treatment. I was left wondering if this is the norm or simply the planned to timing related to the study and new laser. Kipton did show off the new laser and was quite impressed with its innovations. I still feel it is a mute point. Can’t get better than a 100% CR. And improving safety is of minimal concern because it’s already safe, optimize but don’t delay the trial
macer
Bullboard Posts